Ovid Therapeutics Inc (NAS:OVID)
$ 3 -0.01 (-0.33%) Market Cap: 212.83 Mil Enterprise Value: 138.27 Mil PE Ratio: 0 PB Ratio: 2.71 GF Score: 45/100

Ovid Therapeutics Inc. - Special Call Transcript

Jun 17, 2020 / 05:00PM GMT
Release Date Price: $5.43 (-0.82%)
Operator

Good afternoon, ladies and gentlemen. Thank you for standing by and welcome to the Ovid Therapeutics webinar. (Operator Instructions)

It is now my pleasure to turn the call over to Dr. Jeremy Levin, Chairman and CEO of Ovid Therapeutics. Please go ahead.

Jeremy Max Levin
Ovid Therapeutics Inc. - Chairman & CEO

Thank you, Jonathan. Hello, everyone. Thank you for joining us today. As we promised, we would provide an information day on 935. And before I start into that, this is in fact -- I'd like you please to take note of the forward-looking statements. And obviously, as a public company, these are important.

Today's talk will be given by a number of different people. I would like to just say we made a promise to the investment committee that we would educate you as much as possible about 935. And to do that today, we've lined up the best possible array of people that we could in this short period of time so that for a short period of time, you'll have the chance to ask questions of them and get a much deeper appreciation of what we're

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot